Expediting CAR T-Cell Therapy Development Using High-Throughput Technologies
In recent years, researchers have achieved a breakthrough in preventing cancer cells from evading the immune system using CAR T-cell therapy. Despite the success of CAR T-cell therapies in treating blood- and marrow-based cancers, many challenges currently limit their use in treating other types of cancers.
Read about the technological and clinical hurdles facing CAR T-cell therapies and their application to solid tumors. See how high-throughput assays provide a cost-effective route for the development of CAR-T cells, including topics on:
- Tracking CAR T-cell responses with flow cytometry
- Using ddPCR for CAR gene quality control
- Minimizing CAR T-cell therapy side effects
Download the Article
Share a little information with us to access the entire article now.
Thank you for your interest in ! Access the article here.View Article
Content you'll also find interesting